ATARA Biotherapeutics (ATRA) Misses Q1 EPS by 29c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of ($0.29). Revenue for the quarter came in at $520 thousand.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Nano Nuclear In Early Investment Talks From UAE Firm - Semafor
• Bed Bath & Beyond outlines plan to connect housing services
• Atlas Lithium receives expansion permit for Neves lithium project in Brazil